Humanwell Pharmaceutical US

Mallinckrodt, Inc.

Yichang Humanwell Pharmaceutical Co., Ltd.

Yichang Humanwell Pharmaceuticals Co. Ltd.

Jun Yang

Subo Liao

Stephen H Wu

Cliff J Herman

Zongquan Liao

Tianpeng Xie

Jinliang Lv

Jueyuan Gao

Quanli Yang

Hao Zhou

Lei Wang

Hong Du

Xueming Wu

Jianbo Yu

Lie Li

Jie Li

Zejian Ding

Wentao Du

Baohua Yue

Renhe Qiu

Described herein are new pharmaceutical formulations, their preparation, and their use for pain treatment. In particular, described herein are pharmaceutical formulations of the analgesic drug Nalbuphine for intranasal administration.

Pharmaceutical formulations containing Nalbuphine

The present invention provides kappa opioid receptor peptide agonists, methods for preparing these compounds, compositions comprising these kappa opioid receptor peptide agonists, and methods of using the kappa opioid receptor peptide agonists to treat pain or other conditions.

Kappa opioid receptor peptide amide ligands

The present invention provides compounds which are selective kappa-opioid receptor agonist, method of preparation of these compounds, compositions that comprise these compounds, and methods for treating kappa-opiod receptor agonist related medical disorders.

Peptides for treatment of medical disorders

The present invention related to novel morphinans, compositions comprising the novel morphinans, and their uses as agonists of the kappa opioid receptor.

Morphinans useful for treating medical disorders

The present invention provides methods for delivery of therapeutic agents to a subject using multi-component liposomal systems. The methods include administration of a therapeutic liposome containing an active agent, followed by a administration of an attacking liposome that induces release of the agents from the therapeutic liposome.

Combinational liposome compositions for cancer therapy

Growing community of inventors

Ballwin, MO, United States of America

Jun Yang